KINISOQUIN
Dead / Abandoned — Abandoned — failure to respond (as of 16 Dec 2024)
What this means for you
This application is over — abandoned 04 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88836223
- Mark type
- Stylized text
- Filed
- 16 Mar 2020
- Published for opposition
- 02 Mar 2021
- Abandoned
- 04 Dec 2024
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19
Owner
- Quercis Pharma AG, Zug, CH
- Quercis Pharma AG, Zug, CH
Prosecution history
- 16 Dec 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 16 Dec 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 03 Sept 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 03 Sept 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 03 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Jun 2024 — NON-FINAL ACTION E-MAILED
- 03 Jun 2024 — SU - NON-FINAL ACTION - WRITTEN
- 03 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Apr 2024 — USE AMENDMENT FILED
- 29 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
- 28 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Oct 2023 — SOU EXTENSION 5 GRANTED
- 20 Oct 2023 — SOU EXTENSION 5 FILED
- 20 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED